Inhibition of PAD4 disrupts NET formation and shows therapeutic potential for lupus activities in various mouse models.36, 37 Thus, NETs may constitute a promising target for mitigating SLE. The gene discussed is PADI4; the disease is systemic lupus erythematosus.